. Author manuscript; available in PMC: 2015 Aug 5.

Published in final edited form as: Nat Genet. 2009 Jan 18;41(2):221–227. doi: 10.1038/ng.296

Table 4.

Joint analysis of rs401681(C) and rs2736098(A) of BCC and cancers of the lung, bladder, prostate and cervix

Cancer type	# populations	rs401681(C) adjusted for rs2736098(A)			rs2736098(A) adjusted for rs401681(C)
Cancer type	# populations	OR	95% CI	P value	OR	95% CI	P value
Basal cell carcinoma	2	1.20	1.10–1.31	7.8×10⁻⁵	1.09	0.99 –1.21	0.091
Lung cancer	3	1.11	1.01–1.21	0.024	1.14	1.03–1.25	0.010
Bladder cancer	9	1.07	1.00–1.16	0.036	1.12	1.04–1.20	0.0034
prostate cancer	4	1.01	0.95–1.08	0.68	1.13	1.05–1.21	0.0015
Cervical cancer	1	1.27	1.03–1.55	0.022	0.97	0.77–1.22	0.80